013110000a22002530004500003000900000005001700009008004100026040002800067041000800095100003400103245013800137246009100275260005300366300002900419502009000448520031100538530002200849653002600871653002800897653002700925700003700952700003500989856003301024EG-GICUC20250223030739.0070111s2006    ua d   f m    000 0 eng d  aEG-GICUCbengcEG-GICUC0 aEng0 aHaidy Atef Abass Mostafa Ebid12aA Biopharmaceutic Study on Citalopram Hydrobromide / cHaidy Atef Abass Mostafa Ebid ; Supervised Ahmed Abd El bary , Nagwa Ali Sabri15aدراسة بيوصيدلية على السيتالوبرام هايدروبروميد  aCairo : bHaidy Atef Abass Mostafa Ebid , c2006  a213P : bcharts ; c30cm  aThesis (M.Sc.) - Cairo University - Faculty Of Pharmacy - Department Of Pharmaceutics  aBecause these drugs , which are as potent antidepressants as the tricyclics , are devoid of most of the secondary effects of the latter drugs (orthostatic hypotension , weight gain , dry mouth , etc , mainly caused by their capacity to block alpha1 - adrenergic , H1 histaminergic and muscarinic receptors)  aIssued also as CD 4aBiopharmaceutic Study 4aCitalopram Hydrobromide 4apotent antidepressants0 aAhmed Abd El bary , eSupervisor0 aNagwa Ali Sabri , eSupervisor  uhttp://172.23.153.220/th.pdf